Pharmacological Agents Affecting Emesis : A Review (Part II)
- PMID: 28421555
- DOI: 10.2165/00003495-199243040-00003
Pharmacological Agents Affecting Emesis : A Review (Part II)
Abstract
Part I of this article reviewed the pathophysiology of emesis, and its pharmacological treatment. Drug-induced vomiting was also discussed. In the second part of the review, other common causes of vomiting are considered.The basis of the use of antiemetics in morning sickness and migraine is still obscure; for the latter, serotonin 5-HT1 receptor agonists, 5-HT3 receptor antagonists and dopamine D2 receptor antagonists are effective. For motion sickness, control can be achieved with various antagonists of muscarinic or histamine H1-receptors. Centrally active adrenoceptor agonists in combination with a muscarinic antagonist or H1-receptor antagonist may offer better control of motion sickness and its associated symptoms than either antagonist alone; based on clinical studies, post-operative vomiting after opiate administration appears to be controlled by blocking dopamine D2, histamine H1-or muscarinic receptors.Radiation therapy appears to be similar to cytotoxic therapy in that the mediators produced or released by radiation activate both peripheral and central sites involved in the vomiting reflex. Blockade of dopamine D2 and 5-HT3 receptors may be effective.
Similar articles
-
Pharmacological agents affecting emesis. A review (Part II).Drugs. 1992 Apr;43(4):443-63. doi: 10.2165/00003495-199243040-00003. Drugs. 1992. PMID: 1377113 Review.
-
Pharmacological agents affecting emesis. A review (Part I).Drugs. 1992 Mar;43(3):295-315. doi: 10.2165/00003495-199243030-00002. Drugs. 1992. PMID: 1374316 Review.
-
Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.Pharmazie. 2005 Feb;60(2):83-96. Pharmazie. 2005. PMID: 15739895 Review.
-
Clonidine-induced emesis: a multitransmitter pathway concept.Pharmacol Res. 1997 Apr;35(4):287-97. doi: 10.1006/phrs.1997.0133. Pharmacol Res. 1997. PMID: 9264044
-
BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.J Pharmacol Exp Ther. 1988 Mar;244(3):830-7. J Pharmacol Exp Ther. 1988. PMID: 2978041
Cited by
-
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns.Life (Basel). 2021 Dec 12;11(12):1392. doi: 10.3390/life11121392. Life (Basel). 2021. PMID: 34947923 Free PMC article. Review.
-
Treatment of nausea and vomiting in terminally ill cancer patients.Drugs. 2008;68(18):2575-90. doi: 10.2165/0003495-200868180-00004. Drugs. 2008. PMID: 19093700 Review.
-
Cancer cachexia, mechanism and treatment.World J Gastrointest Oncol. 2015 Apr 15;7(4):17-29. doi: 10.4251/wjgo.v7.i4.17. World J Gastrointest Oncol. 2015. PMID: 25897346 Free PMC article. Review.
-
Nausea and Vomiting in 2021: A Comprehensive Update.J Clin Gastroenterol. 2021 Apr 1;55(4):279-299. doi: 10.1097/MCG.0000000000001485. J Clin Gastroenterol. 2021. PMID: 33471485 Free PMC article. Review.
-
Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.Drugs. 1993 Jun;45(6):931-952. doi: 10.2165/00003495-199345060-00006. Drugs. 1993. PMID: 7691500 Review.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources